Ryoko Shimizu

Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer

Daichi Fujimoto, Ryoji Kato, Takeshi Morimoto et al. · PLoS ONE · 2016 · 80 citations · Full text

Medicine, Clinical Sciences, Oncology +15

Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis

Daichi Fujimoto, Hiroyuki Ueda, Ryoko Shimizu et al. · Clinical & Experimental Metastasis · 2014 · 60 citations

Medicine, Molecular Medicine, Oncology +17

The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease

Ryoko Shimizu, Daichi Fujimoto, Ryoji Kato et al. · Cancer Chemotherapy and Pharmacology · 2014 · 53 citations

Medicine, Oncology, Pharmacology +10

Transformation to large cell neuroendocrine carcinoma as acquired resistance mechanism of EGFR tyrosine kinase inhibitor

Mariko Kogo, Ryoko Shimizu, Keiichiro Uehara et al. · Lung Cancer · 2015 · 34 citations

Medicine, Oncology, Pharmacology +16

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma

Yuki Sato, Daichi Fujimoto, Keiichiro Uehara et al. · BMC Cancer · 2016 · 27 citations · Full text

Medicine, Oncology, Pathology +17